Their functions in cancer are dualistic: certain SIRTs (e.g., SIRT1) can promote tumor progression in some cancers, while others (e.g., SIRT6) act as tumor suppressors by maintaining genomic stability. This evidence concerns the gene SIRT6 and neoplasm.